GBS vs. DXR, XAIR, CTCX, CODX, DRIO, MODD, APYX, LNSR, NSPR, and CTSO
Should you be buying GBS stock or one of its competitors? The main competitors of GBS include Daxor (DXR), Beyond Air (XAIR), Carmell (CTCX), Co-Diagnostics (CODX), DarioHealth (DRIO), Modular Medical (MODD), Apyx Medical (APYX), LENSAR (LNSR), InspireMD (NSPR), and Cytosorbents (CTSO). These companies are all part of the "surgical & medical instruments" industry.
Daxor (NASDAQ:DXR) and GBS (NYSE:GBS) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership.
1.3% of Daxor shares are held by institutional investors. Comparatively, 2.8% of GBS shares are held by institutional investors. 60.6% of Daxor shares are held by company insiders. Comparatively, 0.3% of GBS shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Daxor has a beta of -0.45, indicating that its share price is 145% less volatile than the S&P 500. Comparatively, GBS has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500.
GBS's return on equity of 0.00% beat Daxor's return on equity.
In the previous week, GBS had 11 more articles in the media than Daxor. MarketBeat recorded 12 mentions for GBS and 1 mentions for Daxor. GBS's average media sentiment score of 1.18 beat Daxor's score of -0.34 indicating that Daxor is being referred to more favorably in the media.
Daxor has higher earnings, but lower revenue than GBS.
Daxor and GBS both received 0 outperform votes by MarketBeat users.
Summary
Daxor and GBS tied by winning 4 of the 8 factors compared between the two stocks.
Get GBS News Delivered to You Automatically
Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding GBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
